HY-1022

N/A

Report date: 2025/10/24 15:30:04

Base Information

Drug NameHY-1022
Drug Alias NameHY-1022
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungStomach Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSichuan Huiyu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSichuan Huiyu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungStomach Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A